Avadel Pharmaceuticals plc (AVDL)

NASDAQ: AVDL · IEX Real-Time Price · USD

13.89

-0.23 (-1.63%)

At close: Jul 2, 2024, 4:00 PM

13.35

-0.54 (-3.89%)

After-hours: Jul 2, 2024, 5:49 PM EDT

Avadel Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2001
Market Capitalization	1,335	1,268	442	474	389	283	Upgrade
Market Cap Growth	159.03%	186.67%	-6.61%	21.68%	37.67%	196.10%	Upgrade
Enterprise Value	1,283	1,198	477	461	298	343	Upgrade
PE Ratio	-	-7.91	-3.22	-6.12	55.39	-8.51	Upgrade
PS Ratio	24.21	45.35	-	-	17.43	4.78	Upgrade
PB Ratio	17.03	14.45	-20.92	6.05	2.40	-9.68	Upgrade
P/FCF Ratio	-11.95	-9.87	-6.23	-6.12	-7.97	-7.40	Upgrade
P/OCF Ratio	-11.95	-9.87	-6.29	-6.13	-7.99	-7.38	Upgrade
EV/Sales Ratio	23.27	42.85	-	-	13.36	5.80	Upgrade
EV/EBITDA Ratio	-10.14	-8.04	-4.89	-5.60	31.08	-14.54	Upgrade
EV/EBIT Ratio	-10.02	-7.94	-4.81	-5.55	37.71	-13.15	Upgrade
EV/FCF Ratio	-11.55	-9.32	-6.71	-5.97	-6.11	-8.99	Upgrade
Debt / Equity Ratio	0.47	0.40	-6.20	1.85	0.80	-4.27	Upgrade
Debt / EBITDA Ratio	-0.25	-0.24	-1.34	-1.76	13.59	-5.28	Upgrade
Debt / FCF Ratio	-0.29	-0.28	-1.84	-1.87	-2.67	-3.26	Upgrade
Quick Ratio	2.33	3.18	1.73	7.49	14.65	2.01	Upgrade
Current Ratio	2.85	3.64	1.81	9.17	17.44	2.29	Upgrade
Asset Turnover	0.30	0.16	0	0	0.08	0.37	Upgrade
Interest Coverage	-15.99	-15.26	-8.03	-8.37	0.61	-2.09	Upgrade
Return on Equity (ROE)	-149.60%	-211.60%	-3002.20%	-71.50%	5.10%	159.10%	Upgrade
Return on Assets (ROA)	-85.20%	-90.40%	-83.60%	-28.50%	2.40%	-20.60%	Upgrade
Return on Capital (ROIC)	-117.78%	-111.96%	-89.70%	-38.32%	3.12%	-24.38%	Upgrade
Earnings Yield	-11.75%	-12.64%	-31.08%	-16.33%	1.81%	-11.75%	Upgrade
FCF Yield	-9.59%	-10.13%	-16.06%	-16.33%	-12.54%	-13.51%	Upgrade
Buyback Yield / Dilution	-43.53%	-33.41%	-2.66%	-6.54%	-46.89%	-0.21%	Upgrade
Total Shareholder Return	-43.53%	-33.41%	-2.66%	-6.54%	-46.89%	-0.21%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).